# A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

> **NCT03793686** · PHASE1 · TERMINATED · sponsor: **Prolacta Bioscience** · enrollment: 26 (actual)

## Conditions studied

- Clostridium Difficile Diarrhea

## Interventions

- **DRUG:** PBCLN-003
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03793686
- **Lead sponsor:** Prolacta Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-06
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Unable to enroll subjects
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03793686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03793686, "A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03793686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*